These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21929334)

  • 1. Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models.
    Audigé A; Hofer U; Dittmer U; van den Broek M; Speck RF
    Viral Immunol; 2011 Oct; 24(5):375-85. PubMed ID: 21929334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease.
    Gibbert K; Dietze KK; Zelinskyy G; Lang KS; Barchet W; Kirschning CJ; Dittmer U
    J Immunol; 2010 Nov; 185(10):6179-89. PubMed ID: 20943997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections.
    Orange JS; Biron CA
    J Immunol; 1996 Feb; 156(3):1138-42. PubMed ID: 8557990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice.
    Li W; Hofer MJ; Noçon AL; Manders P; Campbell IL
    Virology; 2013 May; 439(2):152-62. PubMed ID: 23490048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
    Le Bon A; Montoya M; Edwards MJ; Thompson C; Burke SA; Ashton M; Lo D; Tough DF; Borrow P
    Eur J Immunol; 2006 Aug; 36(8):2085-93. PubMed ID: 16810633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of chronic to resolved infection by IL-10 blockade is LCMV strain dependent.
    Richter K; Perriard G; Oxenius A
    Eur J Immunol; 2013 Mar; 43(3):649-54. PubMed ID: 23348876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS activity of Pokeweed anti-viral protein (PAP) in mice infected with lymphocytic choriomeningitis virus (LCMV).
    Uckun FM; Rustamova L; Vassilev AO; Tibbles HE; Petkevich AS
    BMC Infect Dis; 2005 Feb; 5():9. PubMed ID: 15725345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Effect of Interferon Lambda Against Lymphocytic Choriomeningitis Virus.
    Lukacikova L; Oveckova I; Betakova T; Laposova K; Polcicova K; Pastorekova S; Pastorek J; Tomaskova J
    J Interferon Cytokine Res; 2015 Jul; 35(7):540-53. PubMed ID: 25830339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of the cytotoxic T lymphocyte response to lymphocytic choriomeningitis virus in mice subjected to chronic social stress.
    Sommershof A; Basler M; Riether C; Engler H; Groettrup M
    Brain Behav Immun; 2011 Feb; 25(2):340-8. PubMed ID: 20974245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection.
    Cousens LP; Orange JS; Biron CA
    J Immunol; 1995 Dec; 155(12):5690-9. PubMed ID: 7499855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production.
    Nguyen KB; Biron CA
    J Immunol; 1999 May; 162(9):5238-46. PubMed ID: 10227998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice.
    Lee LN; Burke S; Montoya M; Borrow P
    J Immunol; 2009 Jun; 182(11):7178-89. PubMed ID: 19454715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
    Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
    Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice.
    Razvi ES; Welsh RM; McFarland HI
    J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.